New data presented at the 2025 San Antonio Breast Cancer Symposium (SABCS) from the NRG/NSABP B-42 trial demonstrated that the Endocrine Activity Index (EAI) identifies postmenopausal women with ...
QuantalX combined transcranial magnetic stimulation and EEG technology in its first-of-its-kind brain network function ...
How high is your risk of developing pancreatic cancer or suffering a heart attack in the next 20 years? A new generative artificial intelligence system called Delphi-2M aims to answer that question ...
“Our research clearly demonstrates that the next major health emergency may not be a sudden new outbreak, but the steady ...
MedPage Today on MSN
New Guidance Released on 'Whether and When' to Stop Psychotropic Meds
New recommendations detail key points of deprescribing ...
(DecisionDx®-Melanoma, TissueCypher®) increased 37% over 2024 Exceeded 2025 guidance with full-year revenue of $344 million Conference call and webcast today at 4:30 p.m. ET FRIENDSWOOD, Texas, Feb.
Background Congenital anomalies are among the common health problems faced by children in low- and middle-income countries, ...
Researchers from KAUST's Smart-Health Initiative and MIT's Jameel Clinic have discreetly surpassed a long-anticipated milestone in medical AI in recent ...
Justin Durham and Alexandra Penn share advice for dental professionals on diagnosing and managing temporomandibular disorder (TMD) patients.
A new consensus statement from the American Society of Clinical Psychopharmacology offers guidance on when — and whether — to discontinue psychotropic medications.
Long-Term Survivorship After Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies The CHAI platform extracted quantitative histomorphologic features from whole-slide images of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results